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Previous studies showed that a considerable proportion of Listeria monocytogenes isolates obtained from
foods carry a premature stop codon (PMSC) mutation in inlA that leads to production of a truncated and
secreted InlA. To further elucidate the role these mutations play in virulence of L. monocytogenes, we created
isogenic mutants, including (i) natural isolates where an inlA PMSC was reverted to a wild-type inlA allele
(without a PMSC) and (ii) natural isolates where a PMSC mutation was introduced into a wild-type inlA allele;
isogenic mutant sets were constructed to represent two distinct inlA PMSC mutations. Phenotypical and
transcriptional analysis data showed that inlA PMSC mutations do not have a polar effect on the downstream
inlB. Isogenic and natural strains carrying an inlA PMSC showed significantly reduced invasion efficiencies in
Caco-2 and HepG2 cell lines as well as reduced virulence in oral guinea pig infections. Guinea pigs were also
orally infected with a natural strain carrying the most common inlA PMSC mutation (vaccinated group),
followed by challenge with a fully virulent L. monocytogenes strain 15 days postvaccination to probe potentially
immunizing effects of exposure to L. monocytogenes with inlA PMSC mutations. Vaccinated guinea pigs showed
reduced bacterial loads in internal organs and improved weight gain postchallenge, indicating reduced severity
of infections in guinea pigs exposed to natural strains with inlA PMSC mutations. Our data support that (i)
inlA PMSC mutations are causally associated with attenuated virulence in mammalian hosts and (ii) naturally
occurring virulence-attenuated L. monocytogenes strains commonly found in food confer protective immunity.
Listeria monocytogenes is a human food-borne pathogen that
can cause a severe invasive disease known as listeriosis in
high-risk populations, including young children, the elderly,
pregnant women, neonates, and other immunocompromised
individuals (45). In 1999, Mead and coworkers estimated that
approximately 2,500 cases of invasive listeriosis, including 500
deaths, occur each year in the United States alone (29). The
infectious dose for L. monocytogenes appears to be high (49),
and the current L. monocytogenes risk assessment by the U.S.
Food and Drug Administration, USDA Food Safety and In-
spection Service, and the Centers for Disease Control and
Prevention (48) estimated that the average individual in the
United States is frequently exposed to L. monocytogenes with-
out developing clinical symptoms. Specifically, the risk assess-
ment estimated that the average person in the United States
consumes a food serving containing low (1  103 CFU) or
intermediate (between 1  103 and 1  106 CFU) levels of L.
monocytogenes 19 and 2.4 times per year, respectively. The risk
assessment also projected that, on average, an individual con-
sumes a food serving contaminated with high levels (between
1  106 and 1  109 CFU) of L. monocytogenes every 2 years
and very high levels (1  109 CFU) of L. monocytogenes
every 3 years (48).
Following a multilocus enzyme electrophoresis study pub-
lished in 1989 (40), a number of phylogenetic and molecular
subtyping studies demonstrated that L. monocytogenes isolates
represent two major genetic lineages (lineages I and II) that
include most natural isolates as well as at least one additional
lineage (lineage III) that is uncommon (30, 32, 50, 52). Previ-
ous studies (16, 31, 50) also found that L. monocytogenes iso-
lates grouping into lineage I, which predominantly contains
serotypes 1/2b and 4b (designated as division I by Pifaretti et
al. [40]), are significantly overrepresented among human clin-
ical cases compared to their presence in foods. Lineage I also
contains two highly clonal serotype 4b strains (epidemic clones
I and II) that have been linked to multiple listeriosis epidemics
worldwide (21) and also are significantly overrepresented among
sporadic listeriosis cases (16). In contrast, several L. monocyto-
genes strains that group into lineage II (designated division II by
Pifaretti et al. [40]), which is predominantly composed of sero-
types 1/2a and 1/2c, are isolated from foods significantly more
frequently than from human listeriosis cases (16).
Internalin A, encoded by inlA, is a bacterial cell wall-anchored
protein that plays a critical role in L. monocytogenes virulence
and, in particular, invasion of human intestinal epithelial cells
(26). Interestingly, a number of different mutations leading to
premature stop codons (PMSCs) in inlA have been observed
among L. monocytogenes isolates collected from multiple coun-
tries, including the United States (33, 39), France (18, 20, 35, 36,
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44), Portugal (12), and Japan (17). Most naturally occurring inlA
PMSCs have been shown to result in the production of a trun-
cated and secreted form of InlA (18, 20, 33), and at least one inlA
PMSC located in the 5 end of the gene abolishes InlA production
(39). Studies in both France and the United States showed that L.
monocytogenes isolates carrying inlA PMSCs constitute a signifi-
cant proportion (30%) of L. monocytogenes isolated from food
but are only rarely isolated from human listeriosis cases (18, 33).
L. monocytogenes isolates that carry inlA PMSCs also demon-
strate an impaired ability to invade Caco-2 human intestinal ep-
ithelial cells (12, 33, 35, 36, 39, 44). While inlA PMSCs are found
in L. monocytogenes isolates representing both lineages, they are
most commonly found among lineage II serotype 1/2a and 1/2c
isolates (18, 33), providing a possible explanation for the under-
representation of lineage II isolates among human clinical cases.
L. monocytogenes populations in food thus include both a consid-
erable subpopulation of strains carrying PMSC mutations in inlA
(18, 33) as well as a subpopulation of fully virulent strains, includ-
ing epidemic clones and other subtypes commonly linked to hu-
man listeriosis cases (16, 21). Humans thus appear to be com-
monly exposed to both subpopulations through consumption of
contaminated foods.
While one previous study used isogenic mutants to evaluate
whether inlA PMSCs are solely responsible for virulence attenu-
ation (34), only tissue culture and chicken embryo infection assays
were used for phenotypic characterization and only a single inlA
PMSC was evaluated. The initial goal of this study was thus to
construct and characterize a number of isogenic L. monocytogenes
mutants to determine (i) if inlA PMSC mutations alone are fully
responsible for attenuated virulence, by using both human tissue
culture cells as well as an oral infection route in guinea pigs
(which express an isoform of the human InlA receptor E-cadherin
that permits InlA binding), and (ii) if inlA PMSC mutations have
a polar effect on expression of the downstream inlB, which en-
codes another internalin that plays a role in virulence (27). Since
our initial data showed that inlA PMSC mutations are responsible
for virulence attenuation and previous studies reported a com-
mon occurrence of these strains in the food supply (16, 18, 33), we
used an oral guinea pig infection model to determine whether L.
monocytogenes carrying an inlA PMSC can function as a natural
vaccine by conferring protective immunity against subsequent ex-
posure to fully virulent L. monocytogenes. The potential for L.
monocytogenes strains carrying inlA PMSCs to function as a nat-
ural vaccine would suggest a complex epidemiology of human
listeriosis, including regular vaccination through natural exposure
to virulence-attenuated L. monocytogenes in foods.
MATERIALS AND METHODS
Bacterial isolates and strains. Two naturally occurring L. monocytogenes strains
with an inlA PMSC, FSL F2-515 (ribotype DUP-1062A; inlA PMSC mutation type
3) and FSL F2-563 (ribotype DUP-1052A; inlA PMSC mutation type 1), were used
in this study (Table 1). These specific inlA PMSC mutations were evaluated because








Genotype or description Reference
10403S 1 1 Wild-type laboratory control strain encoding a full-
length InlA
Bishop et al. (3)
EGD-e Laboratory control strain encoding a full-length InlA
that carries a homologous 3 inlA allelic type to
ribotype DUP-1062A isolates with the exception
of the mutation leading to inlA PMSC type 3
Glaser et al. (15)
FSL W3-084 (HEL-399) 1 1 Isogenic mutant where premature inlA stop codon
mutation type 3 was introduced in a 10403S
background
Nightingale et al. (33)
FSL K4-006 inlA null mutant in a 10403S background Kim et al. (22)
FSL K4-007 inlB null mutant in a 10403S background Kim et al. (22)
FSL K4-009 inlAB null mutant in a 10403S background Kim et al. (22)
FSL F2-515 2 1 Natural ribotype DUP-1062A isolate with premature
inlA stop codon mutation type 3
Nightingale et al. (33)
FSL N4-730 2 1 Isogenic mutant where premature inlA stop codon
mutation type 3 was reverted in a FSL F2-515
background
This paper
FSL F2-563 3 2 Natural ribotype DUP-1052A isolate with premature
inlA stop codon mutation type 1
Nightingale et al. (33)
FSL N4-734 3 2 Isogenic mutant where premature inlA stop codon
mutation type 1 was reverted in a FSL F2-563
background
This paper
FSL F2-245 4 2 Wildtype DUP-1052A isolate with inlA homologous
to FSL F2-563 with the exception of premature
inlA stop codon mutation type 1 and thus
encoding a full-length InlA
Nightingale et al. (33)
FSL N4-733 4 2 Isogenic mutant where premature inlA stop codon
mutation type 1 was introduced in a FSL F2-245
background
This paper
a Paired isogenic mutants that only differ by the presence or absence of each respective premature stop codon mutation in inlA.
b A set of four isogenic mutants assembled to evaluate the virulence of each respective premature stop codon in inlA. Each mutant set includes a natural isolate
carrying a PMSC mutation and its revertant along with a wild-type strain encoding a full-length inlA and its paired mutant, where a given premature stop codon in inlA
was introduced into its parent wild-type strain.
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they represent the two most common strains (EcoRI ribotypes) known to carry these
mutations among food isolates as well as both major L. monocytogenes genetic
lineages (16, 33). EGD-e and FSL F2-245 were used as parent strains carrying an
inlA allelic type that encodes a full-length InlA, as the 3 inlA sequences for these
isolates were identical (with the exception of each PMSC mutation) to FSL F2-515
and FSL F2-563, respectively (33) (Table 1).
Isogenic inlA mutants were constructed using a standard allelic exchange
mutagenesis procedure (6) with the suicide shuttle vector pKSV7, which carries
a temperature-sensitive oriR for Listeria. Sequences for all primers used to
construct mutants are listed in Table S1 of the supplemental material. Mutants
constructed included two revertant mutants, where the inlA PMSC allelic types
in isolates FSL F2-515 and FSL F2-563 were replaced by otherwise-homologous
inlA alleles (which encode a full-length InlA) from EGD-e and FSL F2-245,
respectively (Table 1); this procedure generated isogenic mutants that differed
only by the presence/absence of each respective PMSC. Additionally, we con-
structed two mutant strains in which we introduced the 3 inlA sequences from
FSL F2-563 (inlA PMSC mutation type 1) and FSL F2-515 (inlA PMSC mutation
type 3) into isolates FSL F2-245 and EGD-e, respectively (Table 1); this ap-
proach yielded two strains that differed from their parent strains only by the
presence of an inlA PMSC mutation. All inlA isogenic allelic types generated by
allelic exchange mutagenesis were verified by sequencing the 3 region of inlA as
detailed previously (33). Our strategy yielded two sets of four strains each for
evaluating the effects of inlA PMSC mutations types 1 and 3 on L. monocytogenes
virulence; each set included a natural isolate with or without an inlA PMSC as
well as two corresponding isogenic mutants that differed from their respective
parent strains only by the presence of a single nucleotide polymorphism respon-
sible for a given PMSC in inlA.
Bacterial growth conditions. Bacterial cultures for invasion assays were grown
in brain heart infusion (BHI; Becton Dickson, Sparks, MD) broth under two
conditions: (i) growth at 30°C without shaking to stationary phase as described
previously (33) and (ii) growth at 37°C with shaking to early stationary phase as
detailed previously (22). Bacterial cultures used for guinea pig infection exper-
iments were grown to early stationary phase at 37°C with shaking and frozen at
80°C in phosphate-buffered saline (PBS) with 20% glycerol until use in animal
infection experiments as previously described (14); bacterial viability was deter-
mined by plating appropriate serial dilutions on BHI agar prior to guinea pig
infection experiments.
Cell culture invasion assays. Invasion assays were performed in both human
intestinal epithelial Caco-2 and human hepatic HepG2 cell lines, as efficient
invasion of both of these human cell lines requires internalin A (22). Internalin
B plays a role in the invasion of HepG2 cells, which can be differentiated from
InlA-mediated invasion when bacteria are grown at 37°C with shaking (22).
Invasion assays were performed essentially as previously described (22, 33).
Briefly, semiconfluent monolayers were inoculated with approximately 2  107
L. monocytogenes cells/well in triplicate wells, and the exact inoculum was de-
termined by plating on BHI agar. Inoculated monolayers were incubated at 37°C
for 30 min, followed by three washes with PBS to remove nonadherent bacteria
and the addition of fresh medium without antibiotics. Medium containing 150
g/ml gentamicin was added 45 min postinoculation to kill extracellular bacteria.
At 90 min postinoculation, tissue culture cells were washed three times with PBS
and lysed by addition of cold sterile deionized water with vigorous pipetting.
Intracellular L. monocytogenes cells were enumerated by spread-plating appro-
priate dilutions of the lysed cell suspensions on BHI agar. The standard control
strain L. monocytogenes 10403S (3) and uninoculated BHI broth were included
as controls in each invasion assay. Three independent assays for each strain were
performed in each of the two cell lines. Invasion efficiency was reported as the
natural log of the percentage of initial inoculum recovered after enumeration of
intracellular bacteria.
Statistical analysis of cell culture invasion assays. Natural log-transformed
Caco-2 and HepG2 invasion efficiency data for L. monocytogenes grown at 30°C
were not normally distributed due to the bimodal nature of invasion efficiency for
L. monocytogenes strains with and without inlA PMSC mutations. The Wilcoxon
rank sum test (a nonparametric approximation of the t test) was thus used to
compare the differences in invasion efficiencies between L. monocytogenes strains
with and without inlA PMSC mutations. Transformed invasion efficiency data for
HepG2 invasion assays, where L. monocytogenes was grown at 37°C with shaking,
were distributed normally and were compared by one-way analysis of variance
using Tukey’s studentized residuals to correct for multiple comparisons as im-
plemented in the general linear model procedure in SAS (Statistical Analysis
Systems Software, Cary, NC). P values of 0.05 were considered statistically
significant.
qRT-PCR. To determine if PMSC mutations in inlA have a polar effect on inlB,
quantitative reverse transcriptase PCR (qRT-PCR) was performed to determine
transcript levels for inlA and inlB in paired isogenic L. monocytogenes strains with
and without inlA PMSC mutation type 3 (i.e., strains 10403S, FSL W3-084, FSL
F2-515, and FSL N4-7300) (Table 1). In addition to inlA and inlB, transcript
levels were also determined for two housekeeping genes, gap and rpoB. Total
RNA for qRT-PCR was collected from L. monocytogenes cells grown to early
stationary phase at 37°C with aeration (shaking at 250 rpm) as previously de-
scribed (46). RNA isolation was performed using RNA Protect and the RNeasy
Midi kit (Qiagen) as previously described (46). RNA concentration and purity
were determined by measuring absorbance with an ND-1000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE). qRT-PCR was performed using
previously described TaqMan primers and probes for inlA, inlB, gap, and rpoB
(28, 46), TaqMan One Step RT-PCR Master Mix, and the ABI Prism 7000
sequence detection system (Applied Biosystems, Foster City, CA) as detailed
previously (46). Transcript levels for inlA and inlB were reported as normalized
transcript levels relative to the geometric mean of the transcript levels for the
housekeeping genes gap and rpoB (28).
Intragastric guinea pig infection. As humans and guinea pigs, but not mice or
rats, express a form of E-cadherin that serves as a receptor for the L. monocy-
togenes internalin A protein (25), a guinea pig oral infection model (24) was used
to evaluate the virulence of paired isogenic L. monocytogenes strains with and
without a PMSC mutation in inlA. Animal infection experiments were conducted
as approved by Cornell University Institutional Animal Care and Use Committee
(protocol 2002-0060) and were performed essentially as described previously
(14). Briefly, male juvenile (300-g) pathogen-free Hartley guinea pigs (purchased
from Elm Hill, Chelmsford, MA) were housed in individual cages and acclimated
for a minimum of 5 days prior to infection. Animals were fasted for 12 h prior to
infection and then anesthetized with isoflurane. Anesthetized animals were ga-
vaged using a rubber catheter (Viagon, Norristown, PA), which was used to
deliver 1.5 ml of a calcium carbonate solution (125 g/liter) to buffer stomach pH,
1 ml of inoculum (containing 1  1010 log CFU/ml of a given L. monocytogenes
strain suspended in PBS), followed by 1 ml of PBS. Animals were weighed daily
after infection and were euthanized by CO2 asphyxiation at 72 h postinfection.
Oral guinea pig infection experiments were also conducted to evaluate the
potential of oral infection with a natural L. monocytogenes isolate carrying a
PMSC mutation in inlA to confer protective immunity against subsequent chal-
lenge with a fully virulent L. monocytogenes strain. For these experiments, guinea
pigs were either infected with 1  109 CFU of L. monocytogenes FSL F2-515, a
natural lineage II serotype 1/2a isolate carrying inlA PMSC mutation type 3
(vaccinated), or received a mock infection with PBS (unvaccinated). Fifteen days
later, vaccinated and unvaccinated animals were challenged orally with 1  1010
CFU of either the standard laboratory strain 10403S (lineage II serotype 1/2a) or
the lineage I serotype 4b outbreak strain FSL J1-116 (13); these animals were
also euthanized at 72 h postchallenge. FSL J1-116 was selected as a challenge
strain because this strain belongs to ribotype DUP-1042B, a ribotype previously
estimated to have a lower infectious dose than other subtypes (8).
Microbiological analysis of guinea pig organs. Infection of guinea pigs was
evaluated by testing select organs (i.e., liver, spleen, mesenteric lymph nodes, and
small intestine) to detect and quantify the presence of L. monocytogenes as
previously described (14). Small intestine (ileum) samples were washed and
treated with gentamicin (150 g/ml) prior to homogenization and L. monocyto-
genes enumeration in order to eliminate extracellular microflora. Organs were
homogenized in PBS using sterile blending units (Semi-micro; Eberback, Ann
Arbor, MI), and bacterial numbers were determined by plating appropriate
dilutions on BHI agar plates. Enrichment of organ homogenates (10 ml) in 90 ml
of Listeria enrichment broth (Difco) was also performed (at 37°C for 48 h) to
allow for detection of L. monocytogenes in samples having low bacterial numbers;
enrichments were streaked onto Oxford (Oxoid, Hampshire, United Kingdom)
plates after both 24 and 48 h of enrichment. A previously described PCR-
restriction fragment length polymorphism assay (33) was used to characterize up
to five colonies from each L. monocytogenes-positive organ for vaccinated ani-
mals to differentiate the vaccine strain with an inlA PMSC from the challenge
strain.
Histopathology and immunohistochemistry. Histopathology was performed
on selected tissues from infected guinea pigs as detailed previously (14). Tissue
samples from the liver, mesenteric lymph nodes, small intestine, spleen, and
brain of euthanized guinea pigs were fixed in 10% buffered formalin and subse-
quently processed and embedded in paraffin using Tissue Tek equipment
(Sakura Finetek USA, Inc.). Paraffin-embedded tissues sectioned at 6-m thick-
ness were stained with hematoxylin and eosin for evaluation on an Olympus
BX41 microscope. Pathologist-assigned numeric values ranged from 1 to 11 for
each tissue, with 1 indicating no sign of infection and 11 indicating signs of severe
infection (see Table S2 in the supplemental material).
The tissues detailed above were also used for immunohistochemical detection
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of L. monocytogenes, performed as detailed previously (19) with minor modifi-
cations. Two slides were prepared for each tissue sample; one slide was stained
with polyclonal anti-L. monocytogenes antibody (Becton Dickinson, Sparks MD),
while the second slide was stained with a nonspecific antibody. Slides were then
stained with a secondary anti-immunoglobulin G antibody; the avidin-biotin
system was used to detect bound antibodies, and diaminobenzidine was used as
the chromogenic substrate. Slides were either scored as 0 (i.e., no detectable L.
monocytogenes antigen) or 1 (i.e., detectable L. monocytogenes antigen) by the
pathologist (see Table S3 in the supplemental material). Samples for histopa-
thology and immunohistochemistry were blinded (i.e., the pathologist was not
informed of the treatment received by each animal prior to examination of
tissues), and tissues from uninfected control animals were also submitted for
analyses.
Serology. Serology for L. monocytogenes antibodies was performed on serum
from blood samples collected from the saphenous vein immediately prior to
infection with the vaccine strain and immediately following euthanization at 72 h
postinfection. Serum was obtained from blood samples by centrifugation of
blood samples at 2,700  g for 5 min; serum was aspirated and stored at 80°C.
Bacterial agglutination assays were performed essentially as described by Wesley
et al. (51). To obtain antigens for the agglutination assay, L. monocytogenes
10403S was grown to log phase (optical density at 600 nm, 0.27) at 37°C with
aeration (shaking at 250 rpm), and bacterial cells were collected by centrifuga-
tion. The cell pellet was washed with PBS, fixed with 10% buffered formalin at
25°C for 1 h, washed again with PBS, and resuspended in PBS with 1% bovine
serum albumin (4). In each agglutination assay, rabbit anti-L. monocytogenes
antiserum (Difco) and serum obtained from a negative control animal which was
not infected with L. monocytogenes were included as positive and negative ag-
glutination controls, respectively.
Statistical analysis of guinea pig infection experiments. For the oral guinea
pig infection experiments, designed to evaluate the virulence of L. monocytogenes
strains with and without inlA PMSC mutations, three animals were infected with
each of the four L. monocytogenes strains evaluated. The recovery levels (in log
CFU/g) of L. monocytogenes from organs (i.e., liver, spleen, mesenteric lymph
nodes, and small intestine) were used as the main measure of virulence. L.
monocytogenes numbers recovered were normally distributed, and statistical
analyses were performed using a one-way analysis of variance (ANOVA), as
implemented using the general linear model procedure in SAS (Statistical Anal-
ysis Systems Software, Cary, NC). Tukey’s studentized range test was used to
correct for multiple comparisons. Mean weights for guinea pigs infected with L.
monocytogenes strains with and without a PMSC in inlA postinfection were also
normally distributed, and final weights at 72 h postinfection were compared using
a one-way ANOVA and Tukey’s studentized range test.
For animal infection experiments conducted to evaluate the ability of L.
monocytogenes strains carrying an inlA PMSC mutation to confer protective
immunity, three animals were used in each of the four treatment groups, includ-
ing (i) vaccinated animals (i.e., animals first infected with a strain carrying an inlA
PMSC mutation) challenged with L. monocytogenes 10403S at 15 days postvac-
cination; (ii) vaccinated animals challenged with L. monocytogenes FSL J1-116;
(iii) unvaccinated animals challenged with L. monocytogenes 10403S; and (iv)
unvaccinated animals challenged with L. monocytogenes FSL J1-116. Statistical
analyses were performed on L. monocytogenes numbers recovered in internal
organs (i.e., liver, spleen, mesenteric lymph nodes, and small intestine) as well as
animal weights, similar to the analyses described above. Analyses were per-
formed separately for guinea pigs challenged with the two different strains, as the
challenge strain had a significant effect on L. monocytogenes numbers recovered
from the organs of unvaccinated animals. A number of organ samples were
either (i) negative by direct plating but positive by enrichment or (ii) negative by
both direct plating and enrichment. As a result, bacterial numbers for these
samples were thus reported as either (i) the detection limit of the direct plating
procedure or (ii) the detection limit of the enrichment procedure, respectively.
Normal probability plots indicated these data did not fit a normal distribution,
and a nonparametric approximation to the t test (Wilcoxon rank sum test) was
thus used to compare L. monocytogenes numbers recovered from each organ of
vaccinated and unvaccinated guinea pigs. Final animal weights at 72 h postchal-
lenge for vaccinated and unvaccinated animals were compared using a one-way
ANOVA with Tukey’s correction. Histopathology and immunohistochemistry
data were also analyzed for differences among vaccinated and unvaccinated
animals. Histopathological observations were treated as a continuous dependent
response variable and were analyzed by one-way ANOVA, while immunohisto-
chemistry results were subjected to a chi-square test of independence. In all
cases, P values of 0.05 were considered statistically significant.
RESULTS
L. monocytogenes strains with PMSC mutations in inlA show
reduced invasion efficiency in Caco-2 and HepG2 cells. When
L. monocytogenes strains were grown to stationary phase at
30°C (without shaking), median natural log-transformed
Caco-2 cell invasion efficiencies of L. monocytogenes strains
that encode a full-length InlA ranged from 0.52 to 0.89,
whereas median log-transformed invasion efficiencies of strains
carrying a inlA PMSC mutation ranged from 3.60 to 4.24
(P  0.0001; Wilcoxon rank sum test) (Fig. 1a). Since we
created two sets of paired mutants each containing four iso-
genic strains (one set each for inlA PMSC mutation 1 and 3),
we were also able to evaluate the specific effects of each inlA
PMSC on Caco-2 invasion efficiency. Both a natural strain with
inlA PMSC mutation type 3 (FSL F2-515) and the isogenic
strain where PMSC mutation type 3 was introduced in wild-
type strain 10403S (i.e., FSL W3-084) showed similar low in-
vasion efficiencies (3.87 and 3.97, respectively), compared
to the parent strain 10403S and FSL N4-730, an isogenic mu-
tant of FSL F2-515 where PMSC type 3 was reverted to encode
a full-length InlA (0.52 and 0.63 invasion efficiencies, respec-
tively). Similarly, both a natural strain with PMSC mutation
type 1 (FSL F2-563) and strain FSL N4-733, an isogenic mu-
tant created by inserting PMSC type 1 into FSL F2-245,
showed similar low invasion efficiencies (4.24 and 3.60,
respectively) compared to the parent strain FSL F2-245 (which
encodes full-length InlA) and FSL N4-734, an isogenic mutant
of FSL F2-563 where PMSC type 1 was reverted to encode a
full-length InlA (0.88 and 0.89 invasion efficiency, respec-
tively).
When invasion assays with the two sets of isogenic mutants
described above were performed in the human hepatocyte cell
line HepG2 (using bacteria grown at 30°C without aeration),
results similar to those obtained in Caco-2 cells were observed
(Fig. 1b). Median natural log-transformed HepG2 invasion
efficiencies for L. monocytogenes strains encoding a full-length
InlA ranged from 0.49 to 1.65, whereas median invasion
efficiencies of strains carrying an inlA PMSC mutation ranged
from 4.43 to 5.81 (P  0.001; Wilcoxon rank sum test). As
observed in Caco-2 invasion assays, natural strains with inlA
PMSC mutation types 1 or 3 and strains where these PMSC
types were introduced into a parent strain with full-length InlA
showed similar low invasion efficiencies (Fig. 1b). Further-
more, strains where inlA PMSC mutation types 1 and 3 were
reverted to inlA alleles that encode a full-length InlA showed
significantly increased invasion efficiencies, which did not differ
from those for wild-type strains encoding a full-length InlA.
These data suggest that inlA PMSC mutations types 1 and 3 are
fully responsible for attenuated invasion efficiency for both
Caco-2 and HepG2 cells.
inlA premature stop codons do not have a polar effect on
inlB expression. Nonsense mutations can have a strong polar
effect on downstream genes located in the same operon (9).
Since inlA and inlB are organized in an operon that can be
transcribed bicistronically and inlB is downstream of inlA (27),
we surmised that the presence of a PMSC in inlA may have a
polar effect on expression of inlB. This hypothesis was tested
using both transcriptional profiling of inlA and inlB and a
phenotypic assay to assess InlB functionality (i.e., an invasion
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assay in HepG2 cells). Determination of inlA and inlB tran-
script levels using qRT-PCR for (i) wild-type L. monocytogenes
strain 10403S, (ii) an isogenic strain that carries inlA PMSC
mutation type 3 in a 10403S background (FSL W3-084), (iii) a
natural isolate with inlA PMSC mutation type 3 (FSL F2-515),
and (iv) an isogenic mutant of FSL F2-515 where inlA PMSC
mutation type 3 was reverted to encode a full-length InlA
(strain FSL N4-730) showed similar inlA and inlB transcript
levels. Specifically, normalized log-transformed inlA transcript
levels for 10403S, FSL W3-084, FSL F2-515, and FSL N4-740
FIG. 1. Natural log (LN)-transformed Caco-2 (A) and HepG-2 (B) cell invasion efficiencies for paired isogenic L. monocytogenes strains with
and without a PMSC in inlA that were grown at 30°C without shaking. The two sets of strains used to evaluate the effects of the most common
inlA PMSC mutations on invasion are indicated on the x axis. Strains in the set representing inlA PMSC mutation type 3 include wild-type L.
monocytogenes strain 10403S encoding a full-length InlA, an isogenic mutant where inlA PMSC mutation type 3 was introduced into a 10403S
background (FSL W3-084), a natural isolate carrying inlA PMSC mutation type 3 (FSL F2-515), and its paired revertant mutant (FSL N4-730)
encoding a full-length InlA. Strains included in the set representing inlA PMSC mutation type 1 include a natural isolate carrying inlA PMSC type
1 (FSL F2-563), its paired revertant mutant (FSL N4-734) encoding a full-length InlA, a wild-type isolate encoding a full-length InlA that belongs
to the ribotype associated with PMSC mutation type 1 (FSL F2-245), and an isogenic mutant where PMSC mutation type 1 was introduced in an
FSL F2-245 background (FSL N4-733). The natural log-transformed invasion efficiency of each L. monocytogenes strain is indicated on the y axis.
Each strain was assayed in triplicate in each independent experiment, and three independent invasion experiments were performed for each strain.
Columns represent median invasion efficiencies (data did not fit a normal distribution), and error bars indicate the minimum and maximum
invasion efficiencies observed for each strain. Different letters denote strains with significantly different invasion efficiencies at the P  0.05 level.
A Wilcoxon rank sum test showed that naturally occurring and isogenic L. monocytogenes strains carrying a PMSC in inlA demonstrated
significantly reduced invasion efficiencies in Caco-2 (P  0.0001) and HepG-2 (P  0.001) cells compared to wild-type and revertant mutant strains
carrying an inlA that encodes a full-length InlA.
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were 0.67, 0.51, 0.79, and 0.77, respectively, while inlB
transcript levels for 10403S, FSL W3-084, FSL F2-515, and
FSL N4-730 were 0.84, 0.79, 1.05, and 0.90, respectively
(based on two independent experiments). Overall, these data
support that (i) the presence of a PMSC mutation in inlA does
not affect transcription of inlA or inlB, since transcript levels of
both inlA and inlB were similar for isogenic pairs with and
without a PMSC mutation in inlA, and (ii) that inlA PMSCs do
not have a polar effect on inlB transcription.
HepG2 invasion assays were performed essentially the same,
using L. monocytogenes strains grown at 37°C with shaking, as
previous work showed that InlB-mediated invasion of HepG2
cells for L. monocytogenes grown under these conditions can be
differentiated from InlA-mediated invasion (22). HepG2 inva-
sion assays were performed using a specific set of isogenic L.
monocytogenes strains in a 10403S background, including inlA
(FSL K4-006), inlB (FSL K4-007), inlAB (FSL K4-009), and
a 10403S strain where inlA PMSC mutation type 3 was intro-
duced (FSL W3-084). In these assays, the strain carrying an
inlA PMSC mutation in a 10403S background and the inlA
strain showed similar (P  0.05) invasion efficiencies (6.84
and 6.97, respectively), indicating that an inlA PMSC muta-
tion has the same effect on HepG2 invasion efficiency as an
inlA null mutation. Consistent with our previous study (22), the
inlAB strain showed lower invasion efficiency than the inlA
strain (P 	 0.01) (Fig. 2); in addition, the isogenic mutant with
the inlA PMSC (FSL-W3-084) showed higher HepG2 invasion
efficiency than the inlAB strain (P 	 0.007). Overall, these
data suggest that a PMSC in inlA does not have a polar effect
on inlB, as such an effect would be expected to lead to lower
invasion efficiency for the isogenic strain with the inlA PMSC
than seen for the inlA strain and an invasion efficiency similar
to the inlAB strain.
L. monocytogenes strains with inlA PMSC mutation type 3
show reduced virulence in an oral guinea pig infection model.
As inlA is critical for invasion of intestinal epithelial cells in
humans as well as guinea pigs, we evaluated the virulence of
both natural and isogenic strains with inlA PMSC mutation
type 3 in an oral guinea pig infection model. Both FSL F2-515,
a natural strain with PMSC mutation type 3, and FSL W3-084,
an isogenic strain where PMSC mutation type 3 was introduced
in the wild-type strain 10403S, showed significantly (P  0.05)
lower L. monocytogenes numbers in liver (Fig. 3a) and small
intestine (Fig. 3c) compared to their corresponding isogenic
strains encoding a full-length InlA (i.e., 10403S and FSL N4-
730, respectively). Overall, lower L. monocytogenes numbers
were recovered from the spleens and mesenteric lymph nodes
(Fig. 3b and d) of animals infected with a strain carrying a
PMSC in inlA, even though only L. monocytogenes counts for
the natural isolate with inlA PMSC mutation type 3 (i.e., FSL
F2-515) were significantly (P  0.05) lower compared to the
isogenic revertant mutant of FSL F2-515 (strain FSL N4-730).
Postinfection weight changes in guinea pigs infected with
natural and isogenic strains with inlA PMSC mutation type 3
also supported that strains carrying a mutation leading to a
PMSC in inlA show reduced virulence. While all animals
gained weight 24 h postinfection (Fig. 4), only uninfected (neg-
ative control) animals continued to gain weight at 48 and 72 h
FIG. 2. Natural log (LN)-transformed HepG2 cell invasion efficiencies for paired isogenic L. monocytogenes strains with and without a PMSC
in inlA and null mutant control strains in a laboratory control strain (10403S) background. Bacteria were grown at 37°C with shaking, a condition
shown to differentiate InlB-mediated invasion from InlA-mediated invasion in the cell line (22). Strains evaluated are indicated on the x axis and
include wild-type L. monocytogenes strain 10403S encoding a full-length InlA, an isogenic mutant in which we introduced inlA PMSC mutation type
3 into a 10403S background (FSL W3-084), and three control null mutant strains in a 10403S background, including inlA (FSL K4-006), inlB
(FSL K4-007), and inlAB (FSL K4-009). Invasion efficiency for each L. monocytogenes strain is indicated on the y axis. Each strain was assayed
in triplicate in each experiment, and three independent invasion assays were performed for each strain. Columns represent natural log-transformed
mean invasion efficiencies, and error bars indicate the standard deviations around the mean invasion efficiency observed for each strain.
Transformed invasion efficiencies were analyzed by one-way analysis of variance, and different letters denote strains with significantly different
invasion efficiencies at the P  0.05 level. The isogenic strain where PMSC mutation type 3 was introduced into a 10403S background (FSL
W3-084) showed significantly greater invasion efficiency in HepG2 cells compared to inlAB (FSL K4-009) in the same background, supporting
that PMSC mutations in inlA do not have a polar affect on InlB-mediated invasion of human hepatic cells.
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postinfection. Animals infected with L. monocytogenes strains
encoding a full-length InlA (i.e., 10403S and FSL N4-730)
showed the greatest weight loss, while animals infected with L.
monocytogenes strains carrying an inlA PMSC showed reduced
(FSL F2-515) or limited (FSL W3-084) weight loss (Fig. 4).
Specifically, animals infected with FSL W3-084 (an isogenic
mutant generated from 10403S by introducing inlA PMSC type
3) showed weight gain at 72 h postinfection that differed sig-
nificantly (P  0.05) from that observed for animals infected
with the parent strain 10403S, which showed considerable
weight loss at 72 h postinfection (10%) (Fig. 4). Overall, our
data support that L. monocytogenes carrying inlA PMSC mu-
tation type 3 shows reduced virulence and that the single nu-
cleotide polymorphism that causes inlA PMSC type 3 is spe-
cifically responsible for virulence attenuation.
Exposure of guinea pigs to L. monocytogenes with an inlA
PMSC mutation protects against subsequent challenge with
fully virulent L. monocytogenes. As previous studies showed
that L. monocytogenes isolates with inlA PMSC mutation type
3 represent a considerable proportion of L. monocytogenes
isolated from ready-to-eat foods in the United States (16, 33),
we conducted initial experiments to determine whether oral
FIG. 3. Dot plot of L. monocytogenes populations recovered from organs of guinea pigs orally infected with paired isogenic strains with or
without PMSC type 3 in inlA at 72 h postinfection. L. monocytogenes strains evaluated are indicated on the x axis and include the following: the
wild-type standard laboratory control strain 10403S encoding a full-length InlA (F); FSL W3-083, an isogenic mutant of parent strain 10403S
carrying inlA PMSC mutation type 3 (f); FSL F2-515, a natural isolate carrying inlA PMSC mutation type 3 (); and FSL N4-730, an isogenic
mutant of FSL F2-515, where inlA PMSC mutation type 3 was reverted to encode a full-length InlA (Œ). The y axis denotes L. monocytogenes
populations (in log CFU/g) recovered from the liver (A), mesenteric lymph nodes (B), small intestine (C), and spleen (D) of three guinea pigs
infected with each of the four strains evaluated. Mean L. monocytogenes populations observed for animals infected with each strain are represented
by each of the four short solid horizontal lines in each panel. The limit of L. monocytogenes detection by direct plating for each organ (based on
the average weight observed for each organ) is denoted by the dashed horizontal line near the bottom of each panel. For organs in which L.
monocytogenes was not detected by direct plating but that were positive for L. monocytogenes after selective enrichment, these data were reported
at the detection limit for plating. Overall, one-way analysis of variance indicated a highly significant effect by strain (P  0.0001) but not animal
or day when experiments were performed (P  0.05). Different letters indicate significance at the P  0.05 level with respect to L. monocytogenes
populations recovered from each organ.
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exposure to a natural isolate with an inlA PMSC can confer
protection against subsequent challenge with fully virulent L.
monocytogenes strains. Briefly, guinea pigs were first infected
intragastrically with 1  109 CFU of a natural isolate carrying
inlA PMSC mutation type 3 (vaccinated), while unvaccinated
control animals were orally administered only the carrier fluid
(phosphate-buffered saline). At 15 days postvaccination, both
vaccinated and unvaccinated control animals were orally in-
fected with 1  1010 CFU of either FSL J1-116 (serotype 4b;
human isolate from the 1988 to 1990 listeriosis outbreak in the
United Kingdom [13]) or 10403S (serotype 1/2a [3]). Up to five
L. monocytogenes colonies recovered from each organ of vac-
cinated animals after challenge with a virulent L. monocyto-
genes strain (i.e., 10403S or FSL J1-116) were characterized in
a PCR-restriction fragment length polymorphism assay to de-
termine whether the L. monocytogenes recovered represented
the vaccine strain (with the inlA PMSC) or the challenge strain
(see Table S2 in the supplemental material). Only the vaccine
strain (five out of five colonies tested) was recovered from the
livers of two vaccinated animals challenged with 10403S; in
addition, the mesenteric lymph nodes of one animal contained
a mixed culture (see Table S2 in the supplemental material).
Among animals challenged with FSL J1-116, only the vaccine
strain (five out of five colonies tested) was recovered from the
spleen of two animals. All other organs either yielded only the
challenge strain or were negative for L. monocytogenes. For
statistical analyses, organs where only the vaccine strain was
recovered were considered negative for the challenge strain,
and counts observed for the organ infected with both strains
were reported as the challenge strain.
Overall, vaccinated guinea pigs consistently showed lower L.
monocytogenes numbers in organs compared to unvaccinated
animals (Fig. 5). For example, while the L. monocytogenes
challenge strain was recovered from the spleens of all unvac-
cinated animals, the challenge strain was not recovered from
the spleens of any vaccinated animals. The most striking dif-
ference was observed for the small intestine, where five of six
vaccinated animals were negative for L. monocytogenes and
one was only positive after enrichment, while unvaccinated
animals showed L. monocytogenes numbers between 104 and
105 CFU/g. An overall Wilcoxon rank sum test showed that
vaccination status and challenge strain affected L. monocyto-
genes numbers recovered from organs; only vaccination status
significantly affected L. monocytogenes numbers recovered,
though, when the data for each of the four organs were ana-
lyzed separately. For animals challenged with L. monocyto-
genes 10403S, challenge strain numbers recovered from each of
the four organs analyzed were significantly lower (P  0.05) in
vaccinated animals compared to numbers recovered from un-
vaccinated animals (Fig. 5). For animals challenged with L.
monocytogenes FSL J1-116, challenge strain numbers recov-
ered from mesenteric lymph nodes, small intestines, and
FIG. 4. Postinfection weight changes for guinea pigs orally infected with paired isogenic L. monocytogenes strains with and without PMSC
mutation type 3 in inlA. L. monocytogenes strains evaluated included wild-type 10403S encoding a full-length InlA; isogenic mutant FSL W3-083,
where inlA PMSC mutation type 3 was introduced into a 10403S background; a natural isolate, FSL F2-515, carrying PMSC type 3 in inlA; and
its paired revertant mutant, FSL N4-730, where PMSC mutation type 3 was reverted in a FSL F2-515 background. Weight change was also
monitored for negative control animals, which were only challenged with the carrier solution (phosphate-buffered saline) at the time of
infection. The x axis indicates time postinfection, and the y axis shows the percent weight change postinfection. Lines indicate mean percent
weight change for three animals infected with each of the four strains described above, and error bars show the standard deviations around
mean weight changes for each time point. Different letters at the right end of the graph indicate significant differences at the P  0.05 level with
respect to weight change in animals infected with different strains at 72 h postinfection based on results from a one-way analysis of variance.
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spleens were significantly lower (P  0.05) in vaccinated ani-
mals compared to unvaccinated animals (Fig. 5). Immunohis-
tochemical detection of L. monocytogenes antigens (see Table
S3 in the supplemental material) also supported that vacci-
nated animals showed lower L. monocytogenes loads in the
liver, mesenteric lymph nodes, spleen, small intestine, and
brain compared to vaccinated animals. A chi-square test
showed that tissues with detectable L. monocytogenes antigens
were overall significantly more common (P  0.01) among
organs from unvaccinated animals than from vaccinated ani-
mals.
Both vaccinated and unvaccinated guinea pigs continued to
gain weight during the 15 days postvaccination (see Fig. S1 in
the supplemental material) and showed similar weights at 15
days postvaccination (P  0.05). While vaccinated guinea pigs
showed continued weight gain after oral challenge with either
FIG. 5. Dot plot of L. monocytogenes recovered from organs of vaccinated and unvaccinated guinea pigs. Vaccinated animals were first orally
infected with a serotype 1/2a virulence-attenuated L. monocytogenes strain carrying inlA premature stop codon mutation type 3 (FSL F2-515), while
unvaccinated control animals were infected with only the carrier solution (phosphate-buffered saline) at the time of vaccination. Both vaccinated
and unvaccinated animals were subsequently challenged by infection with a fully virulent L. monocytogenes strain encoding a full-length InlA 15
days later. The x axis indicates treatment groups, including unvaccinated animals challenged by the wild-type serotype 1/2a laboratory control strain
10403S (F), vaccinated animals challenged with 10403S (f), unvaccinated animals challenged with FSL J1-116, a serotype 4b strain from a
listeriosis outbreak (), and vaccinated animals challenged with FSL J1-116 (Œ). The y axis shows L. monocytogenes challenge strain populations
(in log CFU/g) recovered from the liver (A), mesenteric lymph nodes (B), small intestine (C), and spleen (D) of three guinea pigs, representing
each of the four treatments. Short solid horizontal bars indicate the mean L. monocytogenes population observed for animals representing each
treatment. The limit for L. monocytogenes detection by direct plating (based on average weights for each organ) is denoted by the dashed horizontal
line crossing through each panel. The limit for detection of L. monocytogenes by selective enrichment (based on the average weight of each organ
used for enrichment) is denoted by the solid horizontal line crossing through each panel. For organs where L. monocytogenes was detected by
enrichment but not direct plating, data were reported at the detection limit for direct plating. For organs where L. monocytogenes was not detected
by direct plating or enrichment, data were reported at the detection limit for enrichment. Wilcoxon’s rank sum test was used to compare L.
monocytogenes populations from vaccinated and unvaccinated animals, and animals challenged with 10403S and FSL J1-116 were analyzed
separately. Different letters in brackets under the data indicate strains that differed significantly at the P  0.05 level with respect to L.
monocytogenes populations recovered from each organ.
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of the two fully virulent L. monocytogenes strains, unvaccinated
animals showed clear weight loss. Weight gain (at 72 h after
challenge) for vaccinated animals did not differ significantly
from uninfected negative control animals (P  0.05), while
unvaccinated guinea pigs showed significant weight loss at 72 h
postchallenge (P  0.05) compared to negative control and
vaccinated animals (Fig. 6), providing further support for a
reduced severity of infection in vaccinated animals.
Blinded histopathology data showed a difference in severity
of infection signs between vaccinated and unvaccinated guinea
pigs challenged with fully virulent L. monocytogenes. Quanti-
tative histopathology data on liver, mesenteric lymph node,
spleen, small intestine, and brain tissue samples from vacci-
nated and unvaccinated guinea pigs challenged with fully vir-
ulent L. monocytogenes (see Table S4 in the supplemental
material) showed a significant difference in the severity of
infection among vaccinated and unvaccinated guinea pigs (P 	
0.034; one-sided nonparametric t test approximation). Inter-
estingly, all six vaccinated animals evaluated showed signs of
inflammation in the small intestine, while only one of the six
unvaccinated animals evaluated showed signs of inflammation
in the small intestine. This suggests an enhanced local mucosal
immune response in vaccinated animals upon challenge with a
virulent L. monocytogenes.
Guinea pigs exposed to L. monocytogenes with an inlA PMSC
mutation as well as guinea pigs challenged with fully virulent
L. monocytogenes show no evidence for seroconversion. Anti-
bodies against L. monocytogenes were not detected in any of
the serum samples analyzed, including (i) those collected from
all animals immediately prior to vaccination with a L. mono-
cytogenes strain carrying an inlA PMSC and (ii) those from all
animals immediately following euthanization at 72 h postchal-
lenge. These results are consistent with another previous study
that did not detect anti-Listeria antibodies in pregnant guinea
pigs infected with a fully virulent L. monocytogenes strain un-
less a traumatic event such as a stillbirth occurred (53).
DISCUSSION
To date, several distinct mutations leading to PMSCs in the
key virulence gene inlA have been observed in L. monocyto-
genes isolates from France (18, 20, 35, 36, 44), the United
States (33, 39), Portugal (12), and Japan (17). Furthermore,
characterizations of large L. monocytogenes collections from
the United States (16, 33) and France (18) showed that 30%
of L. monocytogenes isolates from food products in these coun-
tries carry inlA PMSCs. To probe the causal relationship be-
tween PMSC mutations in inlA and virulence, we created and
characterized paired isogenic L. monocytogenes strains with
and without inlA PMSCs. As our initial data clearly showed
that L. monocytogenes isolates with inlA PMSC mutations have
reduced virulence, we also explored the potential of a naturally
occurring L. monocytogenes isolate with an inlA PMSC to in-
duce protection against subsequent challenge by fully virulent
FIG. 6. Postchallenge weight changes for vaccinated and unvaccinated guinea pigs. Vaccinated animals were first orally infected with a serotype
1/2a virulence-attenuated L. monocytogenes strain carrying premature inlA stop codon mutation type 3 (FSL F2-515) and subsequently challenged
with a fully virulent strain 15 days postvaccination, while unvaccinated control animals were only challenged with the carrier solution (phosphate-
buffered saline) at the time of vaccination followed by subsequent challenge with a fully virulent strain. Animal treatment groups include
unvaccinated animals challenged with serotype 1/2a wild-type laboratory control strain 10403S encoding a full-length InlA, vaccinated animals
challenged with 10403S, unvaccinated animals challenged with FSL J1-116, a serotype 4b strain from a listeriosis outbreak, and vaccinated animals
challenged with FSL J1-116. Weight change was also monitored for negative control animals, which were gavaged with the carrier solution
(phosphate-buffered saline) at the time of vaccination and challenge. The x axis shows time postinfection and the y axis shows percent weight
change postchallenge. Lines indicate mean weight changes for three animals infected with each strain, and error bars show the standard deviations
around mean weight changes for each time point. Different letters on the right side of the graph indicate strains that differed significantly at the
P  0.05 level with respect to weight change in animals at 72 h postinfection based on results from a one-way analysis of variance.
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L. monocytogenes strains. Overall, our data support that (i)
mutations resulting in inlA PMSC alone are responsible for
reduced invasion and attenuated virulence and (ii) exposure to
a naturally occurring virulence-attenuated L. monocytogenes
strain appears to confer protective immunity against subse-
quent challenge by fully virulent L. monocytogenes strains.
Mutations resulting in a PMSC in inlA alone are sufficient
to cause attenuated virulence. While several different inlA
PMSC mutations have been identified in L. monocytogenes
isolates from foods and other sources, some inlA PMSC mu-
tations have been found to be particularly common. Specifi-
cally, L. monocytogenes strains (EcoRI ribotypes) associated
with inlA PMSC types 1 and 3 represented 30% and 11%,
respectively, of 500 L. monocytogenes isolates from 30,000
ready-to-eat food samples collected in the United States (16,
33). To probe the causal relationship between these two com-
mon inlA PMSCs and virulence, we generated two sets of
isogenic mutants (one to represent each inlA PMSC). Each
mutant set contained two mutant pairs, including (i) a wild-
type strain encoding a full-length InlA and its derived isogenic
mutant, where a given inlA PMSC (i.e., PMSC 1 or 3) was
introduced, and (ii) a natural isolate carrying a given PMSC
and its derived isogenic mutant, where a given inlA PMSC was
reverted to encode a full-length InlA. Characterization of
these isogenic mutant sets clearly showed that introduction of
inlA PMSC 1 or 3 into wild-type strains that previously en-
coded a full-length InlA leads to reduced invasion efficiency in
human intestinal epithelial and hepatic cells (Fig. 1).
Furthermore, isogenic L. monocytogenes mutants and natu-
ral strains carrying inlA PMSC types 1 and 3 showed similar
levels of reduced invasion in cell culture invasion assays. Oral
guinea pig infections with the isogenic L. monocytogenes strain
where inlA PMSC type 3 was introduced showed reduced vir-
ulence (Fig. 3). Combined with our findings that inlA PMSC
type 3 did not have a polar effect on inlB expression, these data
clearly establish that inlA PMSC mutations cause attenuated
virulence. While experimental evaluation of the causal rela-
tionship between inlA PMSCs and human virulence is ethically
not possible, we and other researchers have accumulated an
overwhelming body of evidence supporting that L. monocyto-
genes isolates with inlA PMSCs have attenuated human viru-
lence. This evidence includes (i) the reduced ability of L.
monocytogenes with inlA PMSC mutations to invade human
intestinal epithelial cells and hepatic cells, as reported here
and elsewhere (12, 33, 36, 39, 44), (ii) reduced virulence of L.
monocytogenes with PMSC mutations in inlA demonstrated
using an animal model that is appropriate for evaluating inter-
actions between InlA and the E-cadherin isoform present in
humans, and (iii) significant underrepresentation of L. mono-
cytogenes carrying an inlA PMSC among human clinical cases
(18, 33). Specifically, L. monocytogenes isolates belonging to
ribotype DUP-1062A, which exclusively includes isolates car-
rying inlA PMSC type 3 (33), represented about 30% of food
isolates but 2.0% of human clinical isolates in the United
States (16). Isolates belonging to ribotype DUP-1062A were
also estimated to have a 1,000-fold-lower infectious dose com-
pared to epidemic clone I subtypes, which have commonly
been linked to sporadic and epidemic human listeriosis cases
(8). In addition, a previous study that used an immunoblot
assay to investigate InlA expression status (i.e., expression of a
full-length or truncated InlA) among a large collection of L.
monocytogenes isolates from France showed that L. monocyto-
genes strains expressing a truncated InlA are commonplace in
foods but only cause human disease on very rare occasions
(18). Overall, our findings support that molecular assays (sin-
gle-nucleotide polymorphism genotyping assays) that detect L.
monocytogenes with inlA PMSCs (11) will allow for specific
identification of L. monocytogenes strains with attenuated hu-
man virulence.
We also found that isogenic L. monocytogenes strains where
inlA PMSC types 1 and 3 were reverted to inlA allelic types
encoding a full-length InlA showed a fully restored ability to
invade human intestinal epithelial and hepatic cells (Fig. 1). In
addition, the isogenic L. monocytogenes strain where inlA
PMSC type 3 was reverted to a wild-type inlA showed fully
restored virulence in guinea pigs after oral infection, which was
demonstrated by recovery of significantly higher L. monocyto-
genes numbers in all organs compared to results in animals
infected with the corresponding natural strain carrying inlA
PMSC mutation type 3 (Fig. 3). These findings indicate that
inlA PMSC type 3 is fully responsible for attenuated virulence
and that no other additional mutations, which may have oc-
curred either prior or subsequent to the mutation leading to
the inlA PMSC, contribute to virulence attenuation in the
guinea pig model. Interestingly, Olier et al. (34) previously
found that replacement of a different inlA PMSC mutation
observed among isolates from France in strain LO28 (20) with
the inlA allele from Scott A (which encodes a full-length InlA)
yielded a strain that showed a wild-type Caco-2 invasion phe-
notype. This revertant strain was not characterized in a guinea
pig model and virulence was only partially restored in a chick-
embryo infection assay (34), suggesting the possibility of either
host- or strain-specific effects of inlA premature stop codons.
For example, strain LO28 may demonstrate inherently lower
virulence in chickens compared to strain Scott A.
Naturally occurring virulence-attenuated L. monocytogenes
strains appear to confer protective immunity against subse-
quent challenge by fully virulent L. monocytogenes strains.
Data from the current L. monocytogenes risk assessment by
U.S. agencies (48), which suggest frequent human exposure to
L. monocytogenes through contaminated food, combined with
studies that show a high prevalence of L. monocytogenes with
inlA PMSCs in food (16, 18, 33), indicate that humans are
commonly exposed to virulence-attenuated L. monocytogenes
that carry inlA PMSC mutations. We thus conducted initial
experiments to test the hypothesis that oral exposure to L.
monocytogenes carrying an inlA PMSC mutation may function
as a natural vaccination and thus confer protection against
infection and disease from subsequent exposure to fully viru-
lent L. monocytogenes. Overall, the data from our vaccination
studies provide multiple independent lines of evidence that
oral exposure to L. monocytogenes with an inlA PMSC provides
protection against subsequent exposure to fully virulent strains,
including the following: (i) recovery of significantly lower L.
monocytogenes challenge strain numbers from vaccinated ani-
mals compared to unvaccinated animals; (ii) significantly lower
detection of L. monocytogenes antigens among vaccinated an-
imals compared to nonvaccinated animals determined by im-
munohistochemistry at 72 h postchallenge; (iii) significantly
less severe signs of disease in vaccinated animals compared to
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unvaccinated animals based on histopathological observations
at 72 h postchallenge; and (iv) significantly higher postchal-
lenge weight gain in vaccinated animals compared to unvacci-
nated animals. While a number of previous studies showed that
genetically engineered virulence-attenuated L. monocytogenes
strains can elicit protection against subsequent challenge by
virulent L. monocytogenes (10, 38, 47), only one previous
study (7) evaluated the immunogenicity of a naturally oc-
curring virulence-attenuated L. monocytogenes isolate from
food. Chakraborty et al. (7) specifically showed that intrave-
nous infection of mice with a natural L. monocytogenes isolate
that produces a truncated form of the virulence protein ActA
conferred protection against challenge by a virulent strain 28
days after vaccination. While the previous study by Chakraborty
et al. (7) established that L. monocytogenes strains carrying
naturally occurring virulence-attenuating mutations in actA
confer protective immunity, it did not evaluate this ability using
a natural exposure route (i.e., live oral vaccine). In addition,
strains carrying virulence-attenuating mutations in actA appear
to be rare among natural L. monocytogenes isolates from foods
(43); hence, the ability of L. monocytogenes strains with inlA
PMSCs to induce protective immunity is likely to be more
relevant and important for the overall human host population.
Our observations that L. monocytogenes strains carrying a
PMSC mutation in inlA still disseminate to the spleen and that
vaccinated animals show strikingly reduced recovery of the L.
monocytogenes challenge strain from the small intestine (Fig.
5c) are consistent with data from a study that measured ex-
pression of genes involved in the intestinal immune response in
germ-free transgenic mice that expressed the human form of
E-cadherin and that were challenged with wild-type L. mono-
cytogenes and isogenic inlA, inlAB, and hly mutants (23).
Lecuit et al. (23) specifically showed that the intestinal gene
expression response was similar in mice infected with the inlA
mutant and mice infected with the wild-type strain. Impor-
tantly, the inlA strain was disseminated to the spleen, sug-
gesting L. monocytogenes translocation to the Peyer’s patches
via M-cells by an InlA-independent mechanism (23). These
findings support that naturally occurring virulence-attenuated
L. monocytogenes strains that carry a PMSC in inlA may func-
tion as particularly good oral vaccine strains due to their ability
to elicit a mucosal immune response in the intestine (as sup-
ported by low numbers of L. monocytogenes in the small intes-
tine of vaccinated animals and inflammation in these tissues)
and disseminate to the spleen without causing overt signs of
disease.
While our data provide initial evidence that exposure to an
L. monocytogenes strain carrying an inlA PMSC can protect
guinea pigs against a subsequent challenge with virulent L.
monocytogenes, further experiments are needed to characterize
the specific immune response induced by L. monocytogenes
carrying an inlA PMSC, including the T-cell-mediated immune
response and the duration of protection. While use of a guinea
pig model was appropriate to provide an animal model mim-
icking the InlA–E-cadherin interactions that appear to occur in
a human host (24), the lack of immunological methods and
reagents for the guinea pig prevents in-depth immunological
studies in this model. Future experiments to characterize the
immune response after oral challenge with L. monocytogenes
carrying an inlA PMSC should be possible, though, by using
either transgenic mice that express the human form of E-
cadherin (24) or using L. monocytogenes strains that express a
rationally designed InlA allele that can bind to the murine
E-cadherin (2). Although the current study investigated the
effect of inlA PMSC mutations on virulence in healthy juvenile
guinea pigs, most listeriosis cases occur among neonates and
immunocompromised individuals (45), and future experiments
are necessary to elucidate the role of inlA PMSC mutations in
these specific high-risk host populations. In addition, other
studies (34) provided initial experimental evidence that the
role of a truncated InlA may vary with respect to infection
model and additional experiments (e.g., those using pregnant
or otherwise-immunocompromised guinea pig infection mod-
els) are needed to further probe the relationship between inlA
PMSC mutations and virulence among the most susceptible
host populations.
Our findings that single nucleotide polymorphisms in inlA
leading to a PMSC cause attenuated virulence and that these
strains may represent an effective oral vaccine strain are con-
sistent with findings for other bacterial food-borne pathogens.
For example, the live oral typhoid vaccine Ty21a carries a
frameshift mutation in rpoS, an alternative sigma factor critical
for general stress response and murine virulence, and this
single nucleotide polymorphism is thought to contribute to the
safety of Ty21a as a live oral vaccine strain (41, 42). Interest-
ingly, an enterohemorrhagic Escherichia coli strain genetically
engineered to contain a single nucleotide deletion in eae, which
results in production of truncated intimin protein, was also
found to induce protective immunity in an oral rabbit model of
infection (1). Collectively, data from the L. monocytogenes risk
assessment (48), previous molecular epidemiology studies (16,
18, 33), and the findings of this study suggest that the average
individual is frequently exposed to virulence-attenuated L.
monocytogenes strains through a natural route and that this
exposure may have protective immunizing effects at the pop-
ulation level.
If this is so, it is possible that the reduction of L. monocy-
togenes loads in foods may reduce potentially beneficial expo-
sure to virulence-attenuated L. monocytogenes strains that may
be responsible for conferring protection on immunocompetent
individuals against more virulent strains. While these findings
should not be misconstrued as a recommendation to reduce
existing efforts for controlling L. monocytogenes in the food
supply, our data support the “hygiene hypothesis,” which,
when applied to food safety, proposes that recurrent exposure
to low or intermediate doses of pathogens (or to virulence-
attenuated subtypes) via ingestion of contaminated food may
provide some protection against subsequent exposure to a
given pathogen (5). Interestingly, there is also epidemiological
evidence that supports this hypothesis. For example, an inves-
tigation of a waterborne E. coli O157:H7 outbreak revealed a
significantly lower attack rate for individuals that had previous
long-term exposure to the pathogen and hence appeared to
have acquired some immunity (37). There thus appears to be
emerging evidence that reduced natural exposure to food-
borne pathogens and particularly strains with reduced viru-
lence through contaminated food or water may increase the
risk of infection if exposure to fully virulent strains occurs. It
may be important to quantify whether this effect is important at
a population level through mathematical modeling, which may
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also help determine whether there is a need to develop and use
novel vaccines against selected food-borne pathogens to main-
tain population immunity, while reducing pathogen prevalence
in food and water.
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